Shilpa Medicare gets USFDA nod for cancer treatment injection

NEW DELHI: Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.

The company has received US Food and Drug Administration (USFDA) approval for its ANDA Irinotecan HCL injection USP in the strengths 40 mg/2mL and 100 mg/5mL (20mg/mL) single dose vials, Shilpa Medicare said in a BSE filing.

Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.

Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Irinotecan HCL is approximately USD 18 million.

Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.

  • Related Posts

    Indian nutraceutical industry unites at NUTRAVISION @2047

    The Indian nutraceutical industry came together at NUTRAVISION @2047 — Nutraceutify the Nation for Viksit Bharat, a landmark national symposium held in Mumbai on July 3, to reaffirm a unified…

    Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route

    HYDERABAD: A suspicious air cargo consignment from Laos, declared as ‘coolant’ but allegedly containing high-value anti-cancer drugs worth crores of rupees, has exposed what investigators believe could be a route…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Indian nutraceutical industry unites at NUTRAVISION @2047

    Indian nutraceutical industry unites at NUTRAVISION @2047

    Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route

    Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route

    KGMU urology scam: Medicines worth ₹5 lakh recovered from dismissed staffers’ lockers

    KGMU urology scam: Medicines worth ₹5 lakh recovered from dismissed staffers’ lockers

    Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port

    Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port

    Gujarat to have region specific anti-snake venom in a year

    Gujarat to have region specific anti-snake venom in a year

    Physicians Forum of India all set to bat a 1000 in CME for Healthy India

    Physicians Forum of India all set to bat a 1000 in CME for Healthy India